Skip to main content

Sangamo Therapeutics, Inc 10-Q for FY2020 Q3

Sangamo Therapeutics, Inc (SGMOQ)

10-Q 2020-11-04 For: 2020-09-30
View Original
Added on April 10, 2026

About this 10-Q

Sangamo Therapeutics, Inc filed this 10-Q on November 4, 2020, covering the quarter ended September 30, 2020 (FY2020 Q3).

Headline figures

Quarter ended September 30, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$57.76M
up 163.1% from $21.96M a year earlier
Net loss
$1.55M
compared with a net loss of $27.31M a year earlier